Cytokinetics (CYTK) Files $100M Mixed Shelf

Cytokinetics, Inc. (Nasdaq: CYTK), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Warrants, or any combination thereof.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• Werewolf Therapeutics to merge with Ambros in $150M private placement
• Aveanna selling stockholders launch 15M share secondary offering